Catalyst Wire Dossier Catalyst Wire Dossier

SHR 7280

· Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR 7280, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects [Phase 3]

See pricing